Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
about
Mitochondrial metabolism is regulated by thioredoxin.Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumorsBAP18 coactivates androgen receptor action and promotes prostate cancer progression.Molecular mechanism of prostate cancer cell apoptosis induced by busulfan via adjustment of androgen receptor phosphatizationEndostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study.
P2860
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@ast
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@en
type
label
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@ast
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@en
prefLabel
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@ast
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@en
P2093
P2860
P356
P1476
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
@en
P2093
Anandi Sawant
Diptiman Chanda
Ha-Ram Cha
Igor N Chesnokov
Joo Hyoung Lee
Matthew R Larson
Selvarangan Ponnazhagan
Tatyana Isayeva
P2860
P304
P356
10.1073/PNAS.1417660112
P407
P577
2015-01-20T00:00:00Z